Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Dec 23, 2025

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

122 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
1952 Everest Medicines	HK$46.18	-1.4%	-1.7%	HK$16.3b	HK$63.87	PS17.3x	E119.0%	n/a
2171 CARsgen Therapeutics Holdings	HK$15.23	2.4%	67.7%	HK$8.5b	HK$22.87	PS91x	E118.2%	n/a
1477 Ocumension Therapeutics	HK$7.90	-1.6%	79.1%	HK$6.4b	HK$10.58	PS10.7x	E114.5%	n/a
6185 CanSino Biologics	HK$36.48	-0.7%	23.5%	HK$12.9b	HK$51.66	PS8.4x	E114.2%	0%
2480 Beijing Luzhu Biotechnology	HK$23.36	0.3%	5.0%	HK$4.6b	HK$31.77	PB5.7x	E105.9%	n/a
460 Sihuan Pharmaceutical Holdings Group	HK$1.27	0.8%	95.4%	HK$11.5b	HK$2.00	PS5x	E93.9%	1.7%
1548 Genscript Biotech	HK$13.27	3.4%	32.8%	HK$29.0b	HK$23.49	PE814.9x	E92.9%	0%
9969 InnoCare Pharma	HK$13.13	-1.1%	121.8%	HK$25.3b	HK$19.12	PS14.1x	E81.1%	n/a
2487 Cutia Therapeutics	HK$5.15	-2.3%	-23.0%	HK$1.9b	HK$13.25	PS6.8x	E74.4%	n/a
9606 Duality Biotherapeutics	HK$328.20	5.2%	n/a	HK$29.2b	HK$428.42	PS12.1x	E74.2%	n/a
9995 RemeGen	HK$77.35	1.4%	421.9%	HK$47.0b	HK$79.90	PS17.4x	E68.6%	n/a
2595 GenFleet Therapeutics (Shanghai)	HK$24.80	-10.1%	n/a	HK$9.2b	HK$58.13	PS42.9x	E66.2%	n/a
2629 Mirxes Holding	HK$46.28	-6.9%	n/a	HK$12.6b	HK$100.01	PS76.8x	E62.4%	n/a
1877 Shanghai Junshi Biosciences	HK$23.48	1.7%	95.3%	HK$35.7b	HK$30.99	PS8.8x	E56.8%	n/a
6990 Sichuan Kelun-Biotech Biopharmaceutical	HK$418.40	3.5%	144.4%	HK$97.6b	HK$532.56	PS58.7x	E55.7%	n/a
2228 XtalPi Holdings	HK$9.72	6.5%	77.0%	HK$41.8b	HK$10.12	PS55.5x	E54.7%	n/a
2616 CStone Pharmaceuticals	HK$5.85	4.7%	147.9%	HK$8.6b	HK$13.30	PS38.4x	E52.9%	n/a
9926 Akeso	HK$113.30	-3.1%	88.2%	HK$104.4b	HK$170.67	PS37.6x	E51.9%	n/a
6996 Antengene	HK$4.03	0.7%	520.0%	HK$2.7b	HK$5.74	PS29.3x	E49.7%	n/a
2126 JW (Cayman) Therapeutics	HK$2.73	-3.2%	110.0%	HK$1.1b	HK$6.03	PS5.6x	E40.7%	n/a
9887 Nanjing Leads Biolabs	HK$51.10	-0.9%	n/a	HK$10.2b	HK$81.31	PB87.6x	E40.7%	n/a
1521 Frontage Holdings	HK$1.00	-1.0%	-41.2%	HK$2.0b	HK$1.20	PE68x	E37.0%	n/a
2561 VISEN Pharmaceuticals	HK$36.40	-0.3%	n/a	HK$3.8b	HK$82.02	PS4107.2x	E31.2%	n/a
2186 Luye Pharma Group	HK$2.88	2.1%	33.3%	HK$11.5b	HK$3.58	PE26.2x	E30.7%	0%

Page 1 of 6